Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kseniya B. Isaeva"'
Autor:
Ekaterina I. Alekseeva, Dar’ya D. Van’kova, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko, Maria V. Kurdup, Tatyana V. Radygina, Irina V. Zubkova
Publikováno v:
Вопросы современной педиатрии, Vol 18, Iss 3, Pp 180-186 (2019)
Background. Vaccination coverage in patients with rheumatic diseases remains extremely low. Moreover, infections are the leading cause of death in such patients. Respiratory infections mortality is 2–5 times higher in adults with rheumatoid arthrit
Externí odkaz:
https://doaj.org/article/c1ddff845a8f4a3aad583c5e7e2d0275
Autor:
Ekaterina I. Alekseeva, Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko
Publikováno v:
Вопросы современной педиатрии, Vol 18, Iss 2, Pp 101-108 (2019)
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children wit
Externí odkaz:
https://doaj.org/article/f435a2b7a6334f68b34903bd464f6a05
Autor:
Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Publikováno v:
Вопросы современной педиатрии, Vol 18, Iss 1, Pp 31-40 (2019)
Background. Prognosis of therapy results of patients with the juvenile idiopatic arthritis (JIA) without systematic manifestations is the precondition of their treatment efficiency enhancement.Objective. Our aim was to establish early predictors for
Externí odkaz:
https://doaj.org/article/b1d2caad14ed459997072efece3d67bb
Autor:
Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Yuri M. Dyakonov, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Publikováno v:
Вопросы современной педиатрии, Vol 17, Iss 5, Pp 381-388 (2018)
Background. Tumour necrosis factor alpha inhibitors are widely used in the treatment of juvenile idiopathic arthritis (JIA). To achieve maximum efficiency of genetically engineered biologic drugs, it is necessary to study predictors of the response t
Externí odkaz:
https://doaj.org/article/68a24b7126a14f709b30f765f19ddc19
Autor:
Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Publikováno v:
Вопросы современной педиатрии, Vol 17, Iss 3, Pp 207-215 (2018)
Background. To assign genetically engineered biologic drugs, we need data on the predictors for response to therapy. Prognostic factors for the response to tocilizumab in patients with juvenile idiopathic arthritis (JIA) without systemic symptoms are
Externí odkaz:
https://doaj.org/article/1f3b7fab18664083a274a2fea93d3b74
Autor:
Ekaterina I. Alexeeva, Leyla S. Namazova-Baranova, Tatyana M. Bzarova, Saniya I. Valieva, Rina V. Denisova, Tatyana V. Sleptsova, Kseniya B. Isaeva, Alexandra M. Chomahidze, Nikolay I. Taibulatov, Anna N. Fetisova, Anna V. Karaseva, Alexandr A. Baranov
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Abstract Background The aim of this study was to investigate the efficacy of etanercept treatment and to identify predictors of response to therapy within 12 months in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations.
Externí odkaz:
https://doaj.org/article/2127ac0e78d44a4dbc8dd9e6b0d0ee5b
Autor:
Ekaterina I. Alexeeva, Margarita A. Soloshenko, Tatiana M. Dvoryakovskaya, Olga L. Lomakina, Rina V. Denisova, Kseniya B. Isaeva, Anna V. Karasyova
Publikováno v:
Вопросы современной педиатрии, Vol 16, Iss 2, Pp 142-147 (2017)
Juvenile idiopathic arthritis (JIA) is one of the most frequent and most disabling rheumatic diseases in children. Children with JIA receiving immunosuppressive and genetically engineered biologic drugs belong to the high-risk group for the developme
Externí odkaz:
https://doaj.org/article/b1e3602d1cdc4b63ac762bb9ed3f65e6
Autor:
Margarita A. Soloshenko, Ekaterina I. Alekseeva, Tatiana M. Bzarova, Kseniya B. Isaeva, Rina V. Denisova, Olga L. Lomakina, Elena M. Kaschenko, Anna V. Karaseva
Publikováno v:
Вопросы современной педиатрии, Vol 16, Iss 1, Pp 24-28 (2017)
This review summarizes the international experience of pneumococcal immunization of patients with juvenile idiopathic arthritis (JIA). The high efficiency and safety of pneumococcal vaccines in children with JIA is shown. Numerous studies have demons
Externí odkaz:
https://doaj.org/article/c3237b8c1a594bdbaccfba11cd68e945
Autor:
Ekaterina I. Alekseeva, Тatyana М. Bzarova, Saniya I. Valieva, Rina V. Denisova, Kseniya B. Isaeva, Evgenia G. Chistyakova, Alexandra M. Chomahidze, Tatyana V. Sleptsova, Anna N. Fetisova, Оlga L. Lomakina, Nikolay I. Taybulatov, Anna V. Karaseva
Publikováno v:
Вопросы современной педиатрии, Vol 15, Iss 5, Pp 471-480 (2016)
Background: Addition of genetically engineered biological agents in the paradigm of juvenile idiopathic arthritis (JIA) treatment significantly increased the efficacy of the antirheumatic therapy in patients with this severe chronic disease. Objectiv
Externí odkaz:
https://doaj.org/article/70c30bd358c94f0b8388119ab728446e
Autor:
Tatyana V. Sleptsova, Еkaterina I. Alexeeva, Тatyana М. Bzarova, Kirill V. Savostyanov, Аlexander A. Pushkov, Kseniya B. Isaeva, Rina V. Denisova, Оlga L. Lomakina
Publikováno v:
Вопросы современной педиатрии, Vol 15, Iss 5, Pp 522-526 (2016)
The article presents a case of a successful canakinumab application (preparation of monoclonal antibodies to 1 interleukin) for undifferentiated autoinflammatory syndrome in a patient with refractoriness to oral glucocorticosteroids and genetically e
Externí odkaz:
https://doaj.org/article/7677bc8142954b3b97092bf87c2fc41c